PL2049112T3 - Leczenie infekcji i ich następstw za pomocą połączonych zdysocjowanych agonistów receptora glukokortykoidowego i środków przeciwzapalnych - Google Patents

Leczenie infekcji i ich następstw za pomocą połączonych zdysocjowanych agonistów receptora glukokortykoidowego i środków przeciwzapalnych

Info

Publication number: PL2049112T3
Authority: PL; Poland
Prior art keywords: glucocorticoid receptor; sequelae; combined; receptor agonists; infective agents
Prior art date: 2006-08-07

Application number

PL07813634T

Other languages

English (en)

Inventor

Zhenze Hu

Keith Wayne Ward

Gary Phillips

Raili Kerppola

Original Assignee

Bausch & Lomb

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-07

Filing date

2007-08-01

Publication date

2012-07-31

2007-08-01 Application filed by Bausch & Lomb filed Critical Bausch & Lomb

2012-07-31 Publication of PL2049112T3 publication Critical patent/PL2049112T3/pl

Links

229960005475 antiinfective agent Drugs 0.000 title abstract 2
239000004599 antimicrobial Substances 0.000 title abstract 2
229940124750 glucocorticoid receptor agonist Drugs 0.000 title abstract 2
208000015181 infectious disease Diseases 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 2
JFUAWXPBHXKZGA-IBGZPJMESA-N 4-fluoro-2-[(4r)-5,5,5-trifluoro-4-hydroxy-2-methyl-4-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)pentan-2-yl]phenol Chemical compound C([C@@](O)(CC=1NC2=CN=CC=C2C=1)C(F)(F)F)C(C)(C)C1=CC(F)=CC=C1O JFUAWXPBHXKZGA-IBGZPJMESA-N 0.000 abstract 1
230000000844 anti-bacterial effect Effects 0.000 abstract 1
230000000843 anti-fungal effect Effects 0.000 abstract 1
230000000840 anti-viral effect Effects 0.000 abstract 1
229940121375 antifungal agent Drugs 0.000 abstract 1
239000003904 antiprotozoal agent Substances 0.000 abstract 1
238000002513 implantation Methods 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
238000002347 injection Methods 0.000 abstract 1
239000007924 injection Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

PL07813634T 2006-08-07 2007-08-01 Leczenie infekcji i ich następstw za pomocą połączonych zdysocjowanych agonistów receptora glukokortykoidowego i środków przeciwzapalnych PL2049112T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US83611006P	2006-08-07	2006-08-07
EP07813634A EP2049112B1 (en)	2006-08-07	2007-08-01	Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents
PCT/US2007/074936 WO2008021728A2 (en)	2006-08-07	2007-08-01	Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents

Publications (1)

Publication Number	Publication Date
PL2049112T3 true PL2049112T3 (pl)	2012-07-31

Family

ID=38823623

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07813634T PL2049112T3 (pl)	2006-08-07	2007-08-01	Leczenie infekcji i ich następstw za pomocą połączonych zdysocjowanych agonistów receptora glukokortykoidowego i środków przeciwzapalnych

Country Status (19)

Country	Link
US (1)	US20080033008A1 (pl)
EP (2)	EP2364707B1 (pl)
JP (1)	JP2010500363A (pl)
KR (1)	KR20090040369A (pl)
CN (1)	CN101522196A (pl)
AT (1)	ATE549022T1 (pl)
AU (1)	AU2007284175A1 (pl)
BR (1)	BRPI0714815A2 (pl)
CA (1)	CA2660151C (pl)
CY (1)	CY1113007T1 (pl)
DK (1)	DK2049112T3 (pl)
ES (2)	ES2381045T3 (pl)
MX (1)	MX2009001334A (pl)
PL (1)	PL2049112T3 (pl)
PT (1)	PT2049112E (pl)
SG (1)	SG174031A1 (pl)
SI (1)	SI2049112T1 (pl)
TW (1)	TWI343918B (pl)
WO (1)	WO2008021728A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090042936A1 (en) *	2007-08-10	2009-02-12	Ward Keith W	Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
CA2723954A1 (en) *	2008-05-19	2009-11-26	Alcon Research, Ltd.	Pharmaceutical compositions having carboxyvinyl polymer and povidone polymer
JP2011527709A (ja) *	2008-07-10	2011-11-04	インスパイアーファーマシューティカルズ，インコーポレイティド	眼瞼炎の治療方法
EP2393355A4 (en) *	2009-01-23	2012-07-25	Inspire Pharmaceuticals Inc	METHOD FOR TREATING A DRY EYE WITH AZITHROMYCIN
US20100247606A1 (en) *	2009-03-25	2010-09-30	Allergan, Inc.	Intraocular sustained release drug delivery systems and methods for treating ocular conditions
US20110077270A1 (en) *	2009-04-21	2011-03-31	Pfeffer Bruce A	Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
GR1008168B (el) *	2013-03-14	2014-04-08	"Φαρματεν Α.Β.Ε.Ε.",	Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
CA3123490A1 (en)	2019-01-22	2020-07-30	Akribes Biomedical Gmbh	Selective glucocorticoid receptor modifiers for treating impaired skin wound healing
CN111686239B (zh) *	2019-03-11	2021-12-24	中国科学院微生物研究所	抗真菌化合物的应用
CN115516773A (zh) *	2020-05-08	2022-12-23	瑞典爱立信有限公司	多功能aas接收机
WO2021228349A1 (en)	2020-05-11	2021-11-18	Telefonaktiebolaget Lm Ericsson (Publ)	Efficient prach scheduling
WO2026019875A1 (en) *	2024-07-17	2026-01-22	Jnd Therapeutics, Inc.	Methods and formulations for treatment of liver cancer using trifluridine

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5378475A (en) *	1991-02-21	1995-01-03	University Of Kentucky Research Foundation	Sustained release drug delivery devices
US6051576A (en)	1994-01-28	2000-04-18	University Of Kentucky Research Foundation	Means to achieve sustained release of synergistic drugs by conjugation
ES2079320B1 (es) *	1994-05-17	1996-10-16	Cusi Lab	Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5773019A (en) *	1995-09-27	1998-06-30	The University Of Kentucky Research Foundation	Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) *	1997-08-28	1999-05-11	Control Delivery Systems, Inc.	Sustained release drug delivery devices
US6242196B1 (en) *	1997-12-11	2001-06-05	Dana-Farber Cancer Institute	Methods and pharmaceutical compositions for inhibiting tumor cell growth
WO2000000194A1 (en) *	1998-06-27	2000-01-06	Photogenesis, Inc.	Ophthalmic uses of ppargamma agonists and ppargamma antagonists
US6716830B2 (en) *	1998-09-30	2004-04-06	Alcon, Inc.	Ophthalmic antibiotic compositions containing moxifloxacin
US6726918B1 (en)	2000-07-05	2004-04-27	Oculex Pharmaceuticals, Inc.	Methods for treating inflammation-mediated conditions of the eye
PE20020578A1 (es) *	2000-10-10	2002-08-14	Upjohn Co	Una composicion de antibiotico topico para el tratamiento de infecciones oculares
CA2443937A1 (en) *	2001-04-23	2002-10-31	Randall D. Glickman	Prostanoids augment ocular drug penetration
US7216711B2 (en) *	2002-01-08	2007-05-15	Halliburton Eenrgy Services, Inc.	Methods of coating resin and blending resin-coated proppant
AU2003202216A1 (en) *	2002-01-14	2003-07-30	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
CA2478156C (en) *	2002-03-26	2011-02-15	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2003082787A1 (en)	2002-03-26	2003-10-09	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6897224B2 (en)	2002-04-02	2005-05-24	Schering Ag	Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7074806B2 (en) *	2002-06-06	2006-07-11	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP4503436B2 (ja) *	2002-07-08	2010-07-14	ファイザー・プロダクツ・インク	糖質コルチコイド受容体のモジュレーター
CA2512257A1 (en) *	2003-01-03	2004-07-29	Boehringer Ingelheim Pharmaceuticals, Inc.	1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en)	2003-02-27	2004-11-11	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004097410A1 (en)	2003-04-30	2004-11-11	Pfizer Products Inc.	Screening methods for cataractogenic risk
UY28526A1 (es)	2003-09-24	2005-04-29	Boehringer Ingelheim Pharma	Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7605264B2 (en) *	2004-01-16	2009-10-20	Bristol-Myers Squibb Company	Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7795272B2 (en) *	2004-03-13	2010-09-14	Boehringer Ingelheim Pharmaceutical, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
EP1730145A1 (en) *	2004-03-22	2006-12-13	Boehringer Ingelheim Pharmaceuticals Inc.	Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
US7417056B2 (en) *	2004-11-12	2008-08-26	Schering Ag	5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
DE102004055633A1 (de)	2004-11-12	2006-05-18	Schering Ag	5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
CA2592514A1 (en)	2004-12-27	2006-07-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CN101484187B (zh) *	2006-07-07	2012-12-26	博士伦公司	包含解离的糖皮质激素受体激动剂和免疫抑制剂的用于治疗干眼症的组合物

2007
- 2007-08-01 BR BRPI0714815-1A patent/BRPI0714815A2/pt not_active IP Right Cessation
- 2007-08-01 EP EP11169315A patent/EP2364707B1/en not_active Not-in-force
- 2007-08-01 PL PL07813634T patent/PL2049112T3/pl unknown
- 2007-08-01 AU AU2007284175A patent/AU2007284175A1/en not_active Abandoned
- 2007-08-01 SG SG2011055688A patent/SG174031A1/en unknown
- 2007-08-01 AT AT07813634T patent/ATE549022T1/de active
- 2007-08-01 CN CNA2007800366571A patent/CN101522196A/zh active Pending
- 2007-08-01 US US11/832,265 patent/US20080033008A1/en not_active Abandoned
- 2007-08-01 CA CA2660151A patent/CA2660151C/en not_active Expired - Fee Related
- 2007-08-01 DK DK07813634.8T patent/DK2049112T3/da active
- 2007-08-01 ES ES07813634T patent/ES2381045T3/es active Active
- 2007-08-01 EP EP07813634A patent/EP2049112B1/en not_active Not-in-force
- 2007-08-01 WO PCT/US2007/074936 patent/WO2008021728A2/en not_active Ceased
- 2007-08-01 JP JP2009523900A patent/JP2010500363A/ja active Pending
- 2007-08-01 PT PT07813634T patent/PT2049112E/pt unknown
- 2007-08-01 KR KR1020097004767A patent/KR20090040369A/ko not_active Ceased
- 2007-08-01 MX MX2009001334A patent/MX2009001334A/es active IP Right Grant
- 2007-08-01 SI SI200730912T patent/SI2049112T1/sl unknown
- 2007-08-01 ES ES11169315T patent/ES2403512T3/es active Active
- 2007-08-06 TW TW096128888A patent/TWI343918B/zh not_active IP Right Cessation
2012
- 2012-05-25 CY CY20121100476T patent/CY1113007T1/el unknown

Also Published As

Publication number	Publication date
CA2660151A1 (en)	2008-02-21
EP2049112A2 (en)	2009-04-22
SG174031A1 (en)	2011-09-29
MX2009001334A (es)	2009-02-13
DK2049112T3 (da)	2012-04-23
US20080033008A1 (en)	2008-02-07
ES2403512T3 (es)	2013-05-20
CA2660151C (en)	2012-04-17
KR20090040369A (ko)	2009-04-23
WO2008021728A3 (en)	2008-10-09
JP2010500363A (ja)	2010-01-07
EP2364707A3 (en)	2011-12-28
EP2364707A2 (en)	2011-09-14
HK1131046A1 (en)	2010-01-15
EP2049112B1 (en)	2012-03-14
BRPI0714815A2 (pt)	2013-05-21
TWI343918B (en)	2011-06-21
SI2049112T1 (sl)	2012-05-31
AU2007284175A1 (en)	2008-02-21
WO2008021728A2 (en)	2008-02-21
CN101522196A (zh)	2009-09-02
TW200815410A (en)	2008-04-01
PT2049112E (pt)	2012-06-05
ATE549022T1 (de)	2012-03-15
ES2381045T3 (es)	2012-05-22
CY1113007T1 (el)	2016-04-13
EP2364707B1 (en)	2013-04-03

Publication	Publication Date	Title
PL2049112T3 (pl)	2012-07-31	Leczenie infekcji i ich następstw za pomocą połączonych zdysocjowanych agonistów receptora glukokortykoidowego i środków przeciwzapalnych
IL198073A0 (en)	2009-12-24	Substituted tetrahydropyrrolopyrazine compounds having affinity with the kcnq2/3 k+ channel and use thereof in medicaments
MX2008012573A (es)	2008-10-14	Vendajes para heridas con agentes anti-microbianos y quelantes.
SG127852A1 (en)	2006-12-29	Fluxing compositions
WO2009102962A3 (en)	2009-10-08	Combination of alpha 7 nicotinic agonists and antipsychotics
WO2008005686A8 (en)	2009-02-05	Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
EA033311B1 (ru)	2019-09-30	Производные бензоксаборола в качестве антибактериальных средств
WO2007075965A3 (en)	2007-12-06	Inorganic-organic hybrid thin-film transistors using inorganic semiconducting films
AR051322A1 (es)	2007-01-03	Composiciones de amitraz
IT1392903B1 (it)	2012-04-02	Composizione comprendente un'associazione di principi attivi per uso nel trattamento topico della calvizie
GB2467279B (en)	2013-10-02	Tapes comprising barrier coating compositions and components comprising the same
GB2485117A (en)	2012-05-02	Substituted 1,2-azaborine heterocycles
TW200734344A (en)	2007-09-16	Antibacterial agents
IL196825A (en)	2015-08-31	Preparations and products containing the agonist irl-1620 for the receptor etb for use in the treatment of prostate cancer in combination with chemotherapy
PL1666073T3 (pl)	2009-01-30	Urządzenie do podawania kompozycji przeciwdrobnoustrojowej
SI2064185T1 (sl)	2011-10-28	1H-kinolin-4-onske spojine z afiniteto za receptor GABA, postopki, uporabe in sestavki
WO2008144347A8 (en)	2010-02-25	Combinations comprising a fluoroquinolone for treating, reducing, ameliorating, or preventing infections
ATE486192T1 (de)	2010-11-15	Schutzsystem für motorisierte durchgänge mit zugang für fussgänger
WO2006072113A3 (en)	2007-07-12	Therapeutic composition
TW200628051A (en)	2006-08-01	Magnetic altitude adjusting mechanism
PL2064185T3 (pl)	2011-11-30	Związki 1H-chinolin-4-onowe z powinowactwem do receptora GABA, sposoby wytwarzania, zastosowanie i kompozycje
WO2012061767A3 (en)	2012-06-28	Defensin-like molecules as novel antimicrobial agents
MX2010014248A (es)	2011-03-21	Nuevos antibioticos de trinem e inhibidores de beta-lactamasas.
PL2254765T3 (pl)	2012-03-30	Urządzenie przemieszczające do przesuwnych elementów powiązanych ze środkiem transportu i wyposażony w nie środek transportu
TW200730289A (en)	2007-08-16	Fluxing compositions containing benzotriazoles